You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Embolism and thrombosis

Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

  • NICE guideline
  • Reference number: NG158
  • Published:  26 March 2020
  • Last updated:  02 August 2023
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence

  • Evidence review

  • Evidence reviews

  • I: Diagnosing VTE in people with COVID-19 (PDF 2.34 MB)

    Published:
    02 August 2023
  • A: D-dimer testing in the diagnosis of deep vein thrombosis and pulmonary embolism (PDF 2.95 MB)

    Published:
    26 March 2020
  • B: Use of the pulmonary embolism rule-out criteria (PDF 933 KB)

    Published:
    26 March 2020
  • C: Investigations for cancer (PDF 649 KB)

    Published:
    26 March 2020
  • D: Pharmacological treatment (PDF 8.62 MB)

    Published:
    26 March 2020
  • E: Outpatient treatment for low-risk pulmonary embolism (PDF 679 KB)

    Published:
    26 March 2020
  • F: Duration of pharmacological treatment (PDF 1.73 MB)

    Published:
    26 March 2020
  • G: Economic modelling report on pharmacological treatment (PDF 2.59 MB)

    Published:
    26 March 2020
  • H: Inferior vena caval filters (PDF 1.22 MB)

    Published:
    26 March 2020
  • Other supporting evidence

  • PERC supporting information (PDF 232 KB)

    Published:
    02 August 2023
  • Surveillance report

  • 2022 exceptional surveillance of venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NICE guideline NG158)

  • Appendix A: Summary of evidence from surveillance (PDF 516 KB)

    Published:
    22 September 2022
  • Full guidance

  • Full guideline addendum - November 2015 (PDF 1.44 MB)

    Published:
    25 November 2015
  • Full guideline - June 2012 (PDF 3.07 MB)

    Published:
    22 June 2012
Back to top